Research Reports
Martin & Harris Unlisted Shares
Martin & Harris company logo

Martin & Harris Share Price

PHYSICAL
PUBLIC LIMITED

Price Chart

1W
1M
1Y
MAX
High

₹1,930

Low

₹820

Return

-24.28%

Martin & Harris Essentials

As of April 08, 2026, Martin and Harris Laboratories, Unlisted Shares are trading at ₹920.00 per share and face value is ₹10.00/share, with a 52-week high of ₹920.00 and 52-week low of ₹840.00. The minimun lot size is 220 shares, and the shares are traded on NSDL.
ISIN
info icon
INE03VV01015
Face Value
info icon
10
Total Shares
info icon
39,96,040
Market Cap
info icon
367.64 Cr
Profit After Tax
info icon
40.43 Cr
Total Revenue
info icon
146.15 Cr
P/E
info icon
9.09
P/B
info icon
0.66
Sector
info icon
Health Care
Sub-sector
info icon
Pharmaceuticals
Category
info icon
Micro Cap
Cashflow - Operations
info icon
19.57 Cr

About Martin & Harris

  • Established in 1993,Martin and Harris Labs Ltd. is a vertically integrated biopharmaceutical laboratory offering expertise in Drug Development and Pharmaceutical Manufacturing. A team of competent scientists providing innovative solutions for drug development, along with state-of-the-art manufacturing facilities work passionately towards providing high quality end products and services to ensure complete customer satisfaction.
  • The company has extensive manufacturing plants in Roorkee and Gagreth which have been built in accordance with the WHO GMP guidelines and these have separate quality control units and quality assurance functions to monitor the manufacturing quality of their products.
  • Martin and Harris Laboratories Ltd. operates state-of-the-art manufacturing facilities located at prime locations of the country in order to serve their domestic & International markets. These units have a multi-decade experience of manufacturing different complex dosage forms and specialty formulations
  • Pharmaceutical, medical, chemical, and botanical product manufacture are the main activities of Martin & Harris Laboratories Ltd.
  • In addition to its primary pharmaceutical business, it manages its money by investing in various opportunities that yield strong returns, such as mutual funds, listed and unlisted stocks, etc. Delite Infrastructure Limited, an investment arm of Martin & Harris, handles all the related operations.

Want to See a Detailed Investment Analysis?

Explore in-depth financial analysis, performance metrics, and key disclosures.

Martin & Harris Media

News
Articles
Videos
No News available for this company.

Martin & Harris

₹ 920

cartIcon